Cargando…
Tocilizumab: Cytomegalovirus colitis following off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880035/ http://dx.doi.org/10.1007/s40278-021-91086-1 |
Ejemplares similares
-
Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022) -
Hydroxychloroquine/tocilizumab: Cytomegalovirus enterocolitis and hypovolaemic-shock following off-label use: case report
Publicado: (2020) -
Hydrocortisone/tocilizumab: Cytomegalovirus haemorrhagic enterocolitis and off-label use: case report
Publicado: (2021) -
Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021) -
Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)